Skip to Main
Investment Banking

Advised Europ Assistance Holding S.A.S. on its sale of CareLinx Inc. to Sharecare, Inc.

  • Oppenheimer
  • August 25, 2021

August 2021

Oppenheimer & Co. Inc. acted as Exclusive Financial Advisor to Europ Assistance Holding S.A.S. on its sale of CareLinx Inc. to Sharecare, Inc. (NASDAQ: SHCR)

On August 11th, Sharecare, Inc. (“Sharecare”) acquired CareLinx Inc. (“CareLinx”), the nation's leading digital on-demand platform of over 450,000 tech-enabled care providers. CareLinx delivers intermittent on-demand personal care services in people's homes, while leveraging mobile technology to facilitate rich data capture, population health analytics, and the enabling of real-time care coordination with remote clinical teams. Sharecare (Nasdaq: SHCR) is a leading digital health company, co-founded by Jeff Arnold, that enables people to connect with doctors, insurance companies and employee benefits providers with an all-in-one app.

CareLinx's key differentiation:

  • Three of the largest health plans in the United States and over 1 million Medicare Advantage members have access to CareLinx through their health plans
  • Exclusive offering for AARP members and partnership with the VA
  • Since launching the new business line, Nurse OnDemand, spurred by Covid-19, CareLinx has more than 275 enterprise clients, adding about 40 new clients per month
Carelinx Tombstone
Deal team:

Financial Institutions Investment Banking

Leslie Fenton
Managing Director

Ritendra Roy
Managing Director

Garrett Branisel
Director

DISCLOSURES

This notice is provided for informational purposes only, and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. Nothing contained herein shall constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited.

This notice may contain statistical data cited from third-party sources believed to be reliable, but Oppenheimer & Co. Inc. does not represent that any such third-party statistical information is accurate or complete, and it should not be relied upon as such. All market prices, data and other information are not warranted as to completeness or accuracy and are subject to change without notice.

2021 Oppenheimer & Co. Inc. Transacts Business on all Principal Exchanges and Member SIPC 3731552.1